Richard Kajubi

机构：Lifebox, James Lind Institute, Infectious Diseases Research Collaboration · ORCID：0000-0002-9179-9182

发表论文 74 篇 · 总被引 1247 次 · h-index 16

代表论文

• Neonatal mortality risk of vulnerable newborns: A descriptive analysis of subnational, population‐based birth cohorts for 238 203 live births in low‐ and middle‐income settings from 2000 to 2017 (2023 · BJOG An International Journal of Obstetrics & Gynaecology · 被引 21)
• Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysis (2025 · EClinicalMedicine · 被引 17)
• Effectiveness of sulfadoxine–pyrimethamine plus amodiaquine and dihydroartemisinin–piperaquine for seasonal malaria chemoprevention in Uganda: a three-arm, open-label, non-inferiority and superiority, cluster-randomised, controlled trial (2025 · The Lancet Infectious Diseases · 被引 14)
• Vulnerable newborn types: analysis of subnational, population‐based birth cohorts for 541 285 live births in 23 countries, 2000–2021 (2023 · BJOG An International Journal of Obstetrics & Gynaecology · 被引 14)
• Clinical immunity to malaria involves epigenetic reprogramming of innate immune cells (2024 · PNAS Nexus · 被引 11)
• Neonatal mortality risk of vulnerable newborns by fine stratum of gestational age and birthweight for 230 679 live births in nine low‐ and middle‐income countries, 2000–2017 (2024 · BJOG An International Journal of Obstetrics & Gynaecology · 被引 11)